BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31532704)

  • 1. Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling.
    Gupta N; Kumar R; Seth T; Garg B; Sharma A
    RNA Biol; 2020 Jan; 17(1):98-111. PubMed ID: 31532704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of miR-144/199 promote myeloma pathogenesis via upregulation of versican and FAK/STAT3 signaling.
    Gupta N; Kumar R; Sharma A
    Mol Cell Biochem; 2021 Jun; 476(6):2551-2559. PubMed ID: 33649985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma.
    Gupta N; Kumar R; Seth T; Garg B; Sati HC; Sharma A
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1601-1611. PubMed ID: 30891618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versican and its associated molecules: potential diagnostic markers for multiple myeloma.
    Gupta N; Khan R; Kumar R; Kumar L; Sharma A
    Clin Chim Acta; 2015 Mar; 442():119-24. PubMed ID: 25623955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts.
    Pitari MR; Rossi M; Amodio N; Botta C; Morelli E; Federico C; Gullà A; Caracciolo D; Di Martino MT; Arbitrio M; Giordano A; Tagliaferri P; Tassone P
    Oncotarget; 2015 Sep; 6(29):27343-58. PubMed ID: 26160841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells.
    Abdi J; Rastgoo N; Chen Y; Chen GA; Chang H
    BMC Cancer; 2019 Oct; 19(1):975. PubMed ID: 31638931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway.
    Salem M; O'Brien JA; Bernaudo S; Shawer H; Ye G; Brkić J; Amleh A; Vanderhyden BC; Refky B; Yang BB; Krylov SN; Peng C
    Cancer Res; 2018 Aug; 78(15):4175-4190. PubMed ID: 29748371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
    Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
    Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoregulatory roles of versican proteolysis in the myeloma microenvironment.
    Hope C; Foulcer S; Jagodinsky J; Chen SX; Jensen JL; Patel S; Leith C; Maroulakou I; Callander N; Miyamoto S; Hematti P; Apte SS; Asimakopoulos F
    Blood; 2016 Aug; 128(5):680-5. PubMed ID: 27259980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.
    Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L
    J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation.
    Wang X; Li C; Ju S; Wang Y; Wang H; Zhong R
    Leuk Lymphoma; 2011 Oct; 52(10):1991-8. PubMed ID: 21718132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease.
    Garcia-Gomez A; De Las Rivas J; Ocio EM; Díaz-Rodríguez E; Montero JC; Martín M; Blanco JF; Sanchez-Guijo FM; Pandiella A; San Miguel JF; Garayoa M
    Oncotarget; 2014 Sep; 5(18):8284-305. PubMed ID: 25268740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA-202 in bone marrow stromal cells affects the growth and adhesion of multiple myeloma cells by regulating B cell-activating factor.
    Shen X; Guo Y; Yu J; Qi J; Shi W; Wu X; Ni H; Ju S
    Clin Exp Med; 2016 Aug; 16(3):307-16. PubMed ID: 25971527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible microRNA-210 regulates the DIMT1-IRF4 oncogenic axis in multiple myeloma.
    Ikeda S; Kitadate A; Abe F; Saitoh H; Michishita Y; Hatano Y; Kawabata Y; Kitabayashi A; Teshima K; Kume M; Takahashi N; Tagawa H
    Cancer Sci; 2017 Apr; 108(4):641-652. PubMed ID: 28164410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma.
    Ren Z; Lantermans H; Kuil A; Kraan W; Arenzana-Seisdedos F; Kersten MJ; Spaargaren M; Pals ST
    J Hematol Oncol; 2021 Jan; 14(1):11. PubMed ID: 33436043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel miR-21 target proteins in multiple myeloma cells by quantitative proteomics.
    Xiong Q; Zhong Q; Zhang J; Yang M; Li C; Zheng P; Bi LJ; Ge F
    J Proteome Res; 2012 Apr; 11(4):2078-90. PubMed ID: 22316494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
    Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A
    J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes multiple myeloma resistance through the JAK2/STAT3 pathway.
    Huang J; Huang LQ; He HS; Yan J; Huang C; Wang R; Guan Y; Huang DP
    Life Sci; 2020 Sep; 257():118088. PubMed ID: 32663573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-135a-5p modulates biological functions of thyroid carcinoma cells via targeting VCAN 3'-UTR.
    Zhao X; Sun Z; Li H; Jiang F; Zhou J; Zhang L
    Cancer Biomark; 2017 Aug; 20(2):207-216. PubMed ID: 28869452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223.
    Berenstein R; Nogai A; Waechter M; Blau O; Kuehnel A; Schmidt-Hieber M; Kunitz A; Pezzutto A; Dörken B; Blau IW
    Mol Carcinog; 2016 Dec; 55(12):1927-1939. PubMed ID: 27023728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.